Article
A comperehensive drug repurposing study for Covid19 treatment: Novel putative DHODH…
ChemRxiv: the preprint server for chemistry · 2020 · Burak Berber, author Osman Doluca, author
Key facts
| Title | A comperehensive drug repurposing study for Covid19 treatment: Novel putative DHODH inhibitors show association to Serotonin-Dopamine receptors |
|---|---|
| First author | Burak Berber, author Osman Doluca, author |
| Journal | ChemRxiv : the preprint server for chemistry |
| Published | Aug 3, 2020 |
| Devices mentioned | 213793 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1